Faculty Include

Rick A. Nishimura

MD
Mayo Clinic

Katie Berlacher

MD, FACC
Associate Chief of Education, Heart Vascular Institute, University of Pittsburgh Medical Center

Deepak L. Bhatt

MD, MPH, FACC, FAHA, FSCAI, FESC
Executive Director of Interventional Cardiovascular Programs at Brigham and Women's Hospital Heart & Vascular Center and Professor of Medicine at Harvard Medical School.

Nicole Martin Bhave

MD
Clinical Associate Professor at the University of Michigan

Benjamin Steinberg

MD, MHS
University of Utah

Megan Joseph

MD
University of Michigan

Andrew Harris

MD
University of Michigan

Alison Bailey

MD
Centennial Heart and Vascular

Joseph Ebinger

MD
Cedars-Sinai Medical Center

Erica Spatz

MD
Yale University

Ty Gluckman

MD, FACC, FAHA
Providence St. Joseph Health

Alanna Morris

MD
Emory University

Jeffrey Turner

DO
University of Utah

Khadijah Breathett

MD
University of Arizona

Jonathan Chrispin

MD
Johns Hopkins University

Emily Zeitler

MD
Dartmouth-Hitchcock

Nasrien Ibrahim

MD
Inova Heart and Vascular Institute
Why CHOOSE CurrentMD™ Cardiology?

Made for Physicians Like You

You used to stay current simply by attending annual CME conferences and reading monthly journals, but with the rate of medical advancements, it’s no longer enough. Medical knowledge is doubling every 73 days.
That’s why we invested in upgrading CurrentMD™ Cardiology, to give you access to the most critical knowledge in cardiovascular medicine faster and more effectively in an app that helps you learn anytime, anywhere.
Heart Icon

Be Ready. Be Right. No Matter What.

Never be caught off guard with that new case or rare condition. CurrentMD™ helps you achieve consistent clinical excellence, no matter who or what comes through the door.

add-content icon

Master Instead of Memorize

Information is always a click or two away. CurrentMD™ Cardiology gives you a personalized learning experience with a focus on retention and application to patient care, so you’ll search less and know more.

Personalization Icon

Personalized For You

Add content to your personal playlist to keep track of your progress and easily access your modules on the go.

journal icon

Names You Know. Content That Matters.

No more wondering what you think you need to stay current on. No more missing key updates. Our faculty, from institutions you trust, consistently perform environmental scans and extract what’s most important for you to know.

Computer Screens Icon

Access Learning Activities in Any Format

Whether you’re on a laptop, tablet, or smartphone, complete each learning activity in your preferred format. Watch a video on a lunch break, listen to audio on the commute home, or review transcripts and summaries when you have a moment alone.

certified online Icon

CME/MOC Credit

Earn 100+ AMA PRA Category 1 Credits™ and ABIM MOC points to fulfill your requirements. Plus, new modules are added regularly so you can come back for more!

WHAT'S INSIDE?

Preview The Curriculum

Physical Examination
  • Describe normal and abnormal findings on auscultation
  • Synchronize the auscultatory findings with the EKG throughout the cardiac cycle.
  • Recognize the typical physical findings of disease states, such as myocardial, pericardial and valve disease

 

Aortic Valve Disease

  • Describe the pathophysiology of aortic stenosis (primarily calcific AS, with a brief mention of rheumatic AS)
  • Describe the range of auscultatory findings in a patient with aortic stenosis.
  • Describe echocardiographic findings in aortic stenosis
  • Identify the factors involved in the recommendation of replacement of the aortic valve in a patient with AS

 

  • Describe the pathophysiology of aortic regurgitation
  • Describe the range of auscultatory findings in a patient with aortic regurgitation
  • Describe echocardiographic findings in a patient with aortic regurgitation
  • Identify the factors involved in the recommendation of repair /replacement of the aortic valve in a patient with AR.

 

  • Describe the epidemiology and natural history of bicuspid aortic valve disease Recognize association between bicuspid aortic valve disease and aortopathy

 

Mitral Valve Disease
  • Describe the pathophysiology of mitral stenosis (rheumatic MS, with a brief review of signs/symptoms of rheumatic fever, and calcific MS)
  • Describe the range of auscultatory findings in a patient with mitral stenosis.
  • Describe echocardiographic findings in mitral stenosis (rheumatic and calcific)
  • Identify the factors involved in the recommendation of valvuloplasty/repair/replacement of the mitral valve in a patient with MS.

 

  • Describe the pathophysiology and epidemiology of mitral valve prolapse (myxomatous mitral valve disease versus fibroelastic deficiency)

 

  • Describe the pathophysiology of mitral regurgitation
  • Describe the range of auscultatory findings in a patient with mitral regurgitation.
  • Describe echocardiographic findings in mitral regurgitation
  • Identify the factors involved in the recommendation of repair/replacement of the mitral valve in a patient with MR.

 

Pulmonic Valve Disease

  • Describe the pathophysiology of pulmonic stenosis
  • Describe the range of auscultatory findings in a patient with pulmonic stenosis.
  • Describe echocardiographic findings in patients with PS Identify the factors involved in the recommendation of repair/replacement of the pulmonic valve in a patient with PS.

 

  • Describe the pathophysiology of pulmonic regurgitation
  • Describe the range of auscultatory findings in a patient with pulmonic regurgitation.
  • Describe echocardiographic findings in patients with PR Identify the factors involved in the recommendation of repair/replacement of the pulmonic valve in a patient with PR.

 

Tricuspid Valve Disease

  • Describe the pathophysiology of tricuspid stenosis
  • Describe the range of auscultatory findings in a patient with tricuspid stenosis
  • Identify the factors involved in the recommendation of valvuloplasty/repair/replacement of the tricuspid valve in a patient with TS.

 

  • Describe the pathophysiology of tricuspid regurgitation
  • Describe the range of auscultatory findings in a patient with tricuspid regurgitation.
  • Identify the factors involved in the recommendation of repair/replacement of the tricuspid valve in a patient with TR.

 

Prosthetic Heart Valves

  • Describe the types of prosthetic valves.
  • Identify the factors to consider in the choice of prosthetic valve in the patient with aortic and/or mitral valve disease
  • Select the appropriate long term anticoagulation and/or antiplatelet regimen for patients with prosthetic valves based on valve type and patient characteristics

 

  • List key steps in evaluating prosthetic valves, clinically and echocardiographically, and describe the appropriate type and frequency of follow up
  • Identify potential complications in patients who have received prosthetic valves and outline appropriate management
  • Define appropriate anticoagulation regimens for patients with mechanical prosthetic valves prior to noncardiac surgery
Cardiovascular Infections
  • Describe clinical findings in the patient with endocarditis
  • Describe the diagnostic evaluation for the patient with suspected endocarditis
  • Outline management of the patient with infective endocarditis
Cardiovascular Risk Factors
  • List traditional risk factors that increase a patient’s chance of developing atherosclerotic cardiovascular disease (ASCVD)

 

  • Review non-traditional risk factors for ASCVD

 

  • Describe how to estimate the 10-year risk of cardiovascular disease based on a patient’s risk factors
  • Understand the clinical implications of subclinical ASCVD (e.g., coronary calcium)

 

Chest Pain
  • Describe the range of conditions that may present as chest pain
  • Identify factors that influence the pre-test probability of coronary artery disease

 

  • Outline testing for patients presenting with chest pain in the outpatient setting
  • Outline testing for patients presenting with chest pain to the emergency department

 

Testing and Imaging
  • Review basic tests available to evaluate patients with symptoms/signs suggestive of coronary artery disease (ECG, echocardiography)
  • Review non-invasive functional tests available to evaluate patients with symptoms/signs suggestive of coronary artery disease (exercise electrocardiography, stress echocardiography, SPECT, cardiac magnetic resonance stress testing)
  • Review non-invasive anatomic tests available to evaluate patients with symptoms/signs suggestive of coronary artery disease (CT coronary angiography)

 

  • Review invasive tests available to evaluate patients with symptoms/signs suggestive of coronary artery disease (coronary angiography, IVUS, FFR/iFR/OCT)

 

Stable Ischemic Heart Disease
  • Describe the pathophysiology of stable ischemic heart disease and the range of clinical presentations/features
  • Define angina pectoris and anginal equivalent
  • Describe the steps in the progression of CAD from stable ischemic heart disease to acute coronary syndrome
  • Describe the role of non-invasive testing in patients with stable ischemic heart disease

 

  • List goals of therapy for a patient with stable ischemic heart disease
  • Identify the classes of pharmacologic agents indicated for the management of stable ischemic heart disease
  • List the indications for coronary angiography in the evaluation of patients with known or suspected CAD
  • Identify the indications for revascularization in a patient with stable ischemic heart disease
  • Describe angiographic and other findings that favor revascularization in a patient with stable ischemic heart disease
  • Contrast the benefits of percutaneous vs. surgical revascularization in patients with stable ischemic heart disease

 

  • Identify less common causes of angina
  • Outline the evaluation and management of atypical/variant angina
Optimal DAPT Duration in Coronary Artery Disease
  • Explore the clinical evidence supporting updated ACC/AHA dual antiplatelet therapy (DAPT) guideline recommendations for patients with stable ischemic heart disease

 

  • Understand the recent changes in the ACC/AHA DAPT guideline recommendations regarding prolonged (>12 months) DAPT after percutaneous coronary intervention and/or myocardial infarction
  • Explore risks and benefits associated with prolonged DAPT

 

Acute Coronary Syndrome (coming soon)
  • Describe the pathophysiology of STEMI and the range of clinical presentations/features
  • Identify the benefits of pre-hospital activation of the cardiac catheterization laboratory with STEMI
  • Describe initial evaluation/triage of patients presenting with STEMI
  • Describe initial therapies (beyond reperfusion therapy) for patients with STEMI
  • Describe the use of fibrinolysis for reperfusion, reviewing indications and contraindications
  • Review details related to fibrinolysis, including timing, available agents, concomitant therapies, and complications
  • Describe the use of a pharmaco-invasive strategy after fibrinolysis in STEMI.
  • Describe the use of primary PCI for reperfusion, reviewing indications
  • Compare reperfusion strategies (fibrinolysis vs. primary PCI)
  • Review details related to primary PCI, concomitant therapies, and complications

 

  • Describe the pathophysiology of NSTE-ACS and the range of clinical presentations/features
  • Describe initial evaluation/triage of patients presenting with NSTE-ACS
  • Describe initial therapies for patients with NSTE-ACS
  • Understand the differences between an invasive and conservative approach for NSTE-ACS
  • Outline the role of risk scores for early risk stratification of patients with NSTE-ACS

 

  • Review potential complications with acute coronary syndrome (arrhythmias, heart failure, shock, mechanical complications, other).

 

  • Describe other types of myocardial infarction
  • Recognize unusual causes of myocardial ischemia, including coronary dissection, coronary spasm, and Takotsubo syndrome
  • Understand adjunctive therapies that should be initiated in patients with a recent acute coronary syndrome

 

Secondary Prevention (coming soon)
  • Outline known secondary prevention therapies recommended for patients with a) recent ACS or b) stable ischemic heart disease, with or without revascularization
  • Outline non-pharmacologic strategies to help reduce cardiovascular risk
  • Review current guideline-directed medical therapy and treatment targets for those with ASCVD and hypertension, hypercholesterolemia, and/or diabetes mellitus

 

  • Review indications and benefits of phase 2 cardiac rehabilitation
  • Identify the recommended options for noninvasive follow up of a patient with known coronary artery disease

 

Preoperative Risk Stratification (coming soon)
  • Identify patients with known or suspected CAD or other cardiac diseases who are at risk of cardiac complications during non-cardiac surgery
  • Identify the appropriate type(s) of noninvasive testing to be used in patients with known or suspected CAD who are at risk of cardiac complications during non-cardiac surgery
  • Select and adjust appropriate adjunctive medical therapies for use in the perioperative period to reduce the risk of cardiac complications during and after non-cardiac surgery, including anticoagulating agents
Overview
  • Understand the New York Heart Association classification of heart failure stages
  • Understand the American College of Cardiology/ American Heart Association classification of heart failure stages
  • Distinguish heart failure with reduced ejection fraction from heart failure with a preserved ejection fraction

 

Acute Decompensated Heart Failure
  • Describe the clinical evaluation of the patient presenting with acute decompensated heart failure.
  • Describe the imaging and laboratory evaluation of patients presenting with acute decompensated heart failure
  • Recognize indications for hospital admission for patients presenting with acute decompensated heart failure

 

  • Understand when guideline-directed medical therapies need to be adjusted in patients presenting with acute decompensated heart failure
  • Know the importance of early recognition and initiation of diuretics and their appropriate dosing in patients with acute decompensated heart failure
  • Understand the importance of initiation of guideline-directed medical therapies before hospital discharge

 

Heart Failure with Reduced Ejection Fraction (HFrEF)
  • Describe the clinical evaluation of patients presenting with chronic stable heart failure with reduced EF
  • Describe the imaging and laboratory evaluation of patients presenting with chronic HfrEF

 

  • Understand indication for beta-blockers use per the most recent ACC/AHA/HFSA guidelines
  • Understand indication for mineralocorticoid receptor antagonist use per the most recent ACC/AHA/HFSA guidelines

 

  • Understand indication for ARNI/ACEi/ARB use per the most recent ACC/AHA/HFSA guidelines
  • Understand indication for SGLT2i use per the most recent ACC/AHA/HFSA guidelines

 

Heart Failure with Preserved Ejection Fraction (HFpEF)
  • Describe the clinical evaluation of patients presenting with chronic stable heart failure with preserved EF.
  • Describe the imaging and laboratory evaluation of patients with chronic HfpEF
  • Identify contemporary treatment strategies for a patient with HFpEF

 

Cardiomyopathies
  • Describe various etiologies of dilated CM
  • Describe the association between sleep-disordered breathing and DCM

 

  • Describe the pathophysiology of hypertrophic cardiomyopathy
  • Identify the diagnostic findings in a patient with HCM
  • Provide evidence-based guidance to patients and families regarding genetic testing for HCM
  • Identify patients with HCM who need ICD
  • Formulate a treatment plan for asymptomatic HCM patient

 

  • Describe the pathophysiology of restrictive and other non-dilated cardiomyopathies.
  • Identify 2 classic electrocardiographic findings in a patient with restrictive CM
  • Outline the diagnostic evaluation for a patient with suspected cardiac amyloidosis
  • Identify the different types of amyloidosis
  • Describe the treatment options for the patient with amyloid heart disease

 

  • Know the definition, risk factors, and symptoms of PPCM
  • Understand management options for PPCM
  • Understand risk factors associated with worse outcomes
  • Understand long-term outcomes

 

  • Name the 3 most common chemotherapeutic agents associated with CM

 

  • Describe the clinical presentation of stress-induced cardiomyopathy (Takotsubo)
  • Assess the sudden cardiac death risk in a patient with non-compaction cardiomyopathy.
  • Identify 3 EKG abnormalities associated with ARVD/ARVC.
Management of Patients with Heart Failure and Complex Sleep Apnea
  • Recognize the definitions and pathobiology of obstructive sleep apnea (OSA), central sleep apnea (CSA), and complex sleep apnea and their differential rates among those with heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF)
  • Discuss screening methods for inpatients and outpatients with heart failure (HF) who are at risk for sleep apnea (SA)
  • Describe current treatment options for SA in patients with HF

 

Myocarditis (coming soon)
  • Define myocarditis, identify the common causes, and general monitoring/treatment strategy
  • Understand the presentation and treatment strategies for Giant Cell Myocarditis
  • Recognize and understand treatment strategies for myocarditis in patients treated with immune checkpoint inhibitors

 

Devices for Monitoring and Managing Heart Failure (coming soon)
  • Understand indications for right heart catheterizations
  • Define the indications for an implanted PA monitor and use of sensors including HeartLogic, OptiVol
  • Use of biomarkers (BNP and NT-proBNP) as an adjunct to remote monitoring for volume assessment

 

  • Describe indications for ICD
  • Describe indications for CRT
  • Describe benefits of CRT with regards to outcomes

 

Advanced Heart Failure (coming soon)
  • Describe stage D HF
  • Understand when referral to a HF specialist is needed
  • Describe options for end-stage HF- VAD, TXP, home inotropes/palliation, hospice

 

Mechanical Circulatory Support (coming soon)
  • Identify the indications for short-term left ventricular assist devices (LVAD).
  • Describe contraindications to temporary MCS
  • List the possible complications after percutaneous LVAD

 

  • Identify the indications for long-term left ventricular assist devices (LVAD).
  • Describe contraindications to long-term MCS
  • List the possible complications after durable LVAD

 

Cardiac Transplantation (coming soon)
  • Identify the indications for cardiac transplantation
  • Describe contraindications to transplant

 

  • Understand the basics of induction therapy
  • Describe a typical immunosuppressive regimen

 

  • Describe typical short and long term complications of transplant
  • Outline the management of complications post-heart transplantation
Overview
  • Identify the symptoms of arrhythmia
  • Describe the clinical presentation of arrhythmia
  • Recognize the basic general mechanisms of arrhythmia

 

  • Interpret the indications and findings on 12 lead ECG
  • Interpret the indications, options, and findings on ambulatory electrocardiography studies
  • Identify the (broad) indications for invasive electrophysiology testing, limitations, and appropriate use

 

  • Review the classification of antiarrhythmic medication classes 0-IV & multichannel blockers
  • Describe the mechanism of action of each of the major classes of antiarrhythmic agents
  • Describe the efficacy and safety concerns surrounding these drugs

 

  • List the indications for cardioversion
  • Determine when the pill-in-the-pocket antiarrhythmic therapy is appropriate
  • Identify the rationale and recommendations for TEE prior to cardioversion

 

  • Determine when catheter ablation of AF indicated
  • List the benefits and risks of AF ablation and determine when surgical ablation is appropriate
  • Contrast long term efficacy of pulmonary vein isolation vs antiarrhythmic drug therapy in the patient with paroxysmal atrial fibrillation

 

  • Describe the current pacemaker options (e.g., leadless, single, dual, triple-chamber)
  • Outline the indications for permanent pacemaker implantation in a patient with AV block.
  • Outline the indications for permanent pacemaker implantation in a patient with sinus node dysfunction

 

  • Describe defibrillator device options (transvenous, subcutaneous)
  • Describe the advantages and disadvantages of each device
  • Describe the long-term risks of having a defibrillator

 

Supraventricular Arrhythmias
  • List 4 physiologic causes of sinus tachycardia
  • Contrast the EKG criteria for a PAC with aberrant conduction vs PVC

 

  • Define the 4 types of atrial fibrillation
  • Use current risk scoring systems to evaluate stroke risk in patients with atrial fibrillation
  • Calculate the CHA2DS2 VASc score based on patient description
  • Describe the mechanisms of action of the direct oral anticoagulants (DOACs)
  • Identify the patients who should not be treated with DOACs (who should still get VKA)
  • Summarize the recommendations for the evaluation of a patient with device-detected atrial fibrillation
  • Compare the benefits of rhythm vs rate control in patients with atrial fibrillation
  • Outline the pharmacologic and procedural options to achieve rhythm control in a patient with AFib
  • Describe the pharmacologic options for rate control in patients with atrial fibrillation
  • Select appropriate management options for patients with postoperative atrial fibrillation
  • Describe the approach for emergent management of a patient with AFib who is hemodynamically unstable

 

  • Describe the EKG criteria for atrial flutter
  • Describe clinical factors associated with atypical versus typical atrial flutter

 

  • Describe the differences in mechanism and treatment of those tachycardias (AT, sinus node reentry, AVRNT)
  • Contrast the EKG characteristics among them

 

  • Describe the EKG criteria for SVT List the underlying etiologies of supraventricular tachycardia (SVT)
  • Outline the clinical evaluation of a patient with SVT

 

Current Concepts in Pacing for the Non-EP Cardiologist

  • Review contemporary pacing modalities
  • Describe the structural and clinical consequences of right ventricular (RV) pacing

 

  • Discuss new pacing techniques for the treatment of symptomatic bradycardia and atrioventricular block
  • Contrast the advantages and disadvantages of leadless pacing

 

  • Describe evidence-based guidelines for cardiac resynchronization therapy (CRT)
  • Apply the current electrocardiographic parameters for CRT indications in a patient with Heart Failure with Reduced Ejection Fraction (HFrEF)

 

Ventricular Arrhythmias (coming soon)

  • Review the diagnostic evaluation of a patient with frequent PVCs
  • Outline an algorithm that reflects current recommendations for treating isolated PVCs

 

  • List criteria used to differentiate between VT and SVT with aberrancy in a patient with wide complex tachycardia
  • Describe the urgent management of the patient with ventricular tachycardia
  • Select appropriate treatment options to prevent recurrence of various types of ventricular tachycardia

 

Bradyarrhythmias and Atrioventricular Shock (coming soon)
  • Identify the EKG criteria for sick sinus syndrome

 

  • Contrast the EKG criteria for second degree AV block type 1 (Wenckebach) and type 2

 

  • Define the EKG criteria for complete heart block

 

Syncope (coming soon)
  • Describe the broad classification of syncope by cause
  • Describe the indications and findings of tilt table testing

 

  • Identify 3 cardiac structural abnormalities that are associated with syncope
  • Describe the diagnostic workup to rule out cardiac etiologies of syncope
  • Identify the indications for invasive electrophysiology testing in the patient with syncope

 

  • Describe the diagnostic workup for syncope
  • Describe implantable loop recorders, their implantation, and indications
  • Describe treatment approaches for vasovagal syncope, including exercise protocols

 

Arrhythmia Syndromes (coming soon)

  • Identify the ECG findings associated with Long Q-T syndrome.
  • Describe the distinction between acquired and inherited long QT syndrome
  • Briefly detail the criteria for diagnosis of congenital long QT syndrome

 

  • Broadly describe the diagnosis, clinical features, and management of HCM, ARVC

 

  • Broadly describe the diagnosis, clinical features, and management of Brugada, CPVT, and early repolarization syndrome

 

Cardiac Arrest and Sudden Cardiac Death (coming soon)

  • Describe appropriate diagnostic workup of a patient who has experienced out of hospital sudden cardiac death

  • Describe the recommendations for the secondary prevention of sudden cardiac death

 

Pacemakers and Implantable Cardioverter Defibrillators (coming soon)

  • Identify the 3 and 5 letter codes used to describe pacemaker mode(s)
  • Define the terms upper rate limit, tracking, magnet inhibition

 

  • Identify the indications for ICD implantation in a patient with HFrEF

 

  • Describe the risks of the device implantation procedure
  • Describe the long-term risks of having an implanted device (infection, advisory, malfunction, inappropriate shock, etc.
  • Describe the indications for lead extraction
  • Describe the lead extraction procedure and its risks
  • Describe recommendations for the management of device infections
  • Describe the recommendations for determining PPM EOL and timing for generator replacement
  • Outline the evaluation of a patient who has experienced their first ICD discharge
  • Describe the decision-making process associated with ICD deactivation in a terminally ill patient

 

  • Identify the heart failure patient who may benefit from CRT, based on clinical and EKG criteria
  • Describe the factors associated with CRT response
20,000 PROVIDERS AND COUNTING

The Reviews Are In

93%
Would recommend our CME to their colleagues

Bring back the joy in learning and make CME a part of your lifestyle.

4.5/5
Average rating of our faculty effectiveness

Faculty you respect from institutions across the country.

98.8%
Average relevance rating to everyday practice

Directly apply your knowledge to daily patient care.

INSIDE LOOK

What’s Coming in Spring & Beyond

Rather than having to log into our website whenever you want to learn, take out your smartphone and learn at any time, whether at the gym or on the commute home, no WIFI required!

Rather than taking lengthy “blanket” assessments that take hours to complete, self-assess on topics one by one when you’re ready and instantly see where you stand. From there, our learning technology will personalize your curriculum so that you’ll fill in your gaps of knowledge faster.

SPRING: Heart Failure & Cardiomyopathies, Vascular Disease, Valvular Disease SUMMER: Arrhythmias FALL: Pericardial, Congenital, Systemic Hypertension and Hypotension, Pulmonary Circulation Disorders, Systemic Disorders Affecting Circ System, Normal A & P

Learn from some of the biggest names in cardiology today. Our “legends” include Dr. Rick A. Nishimura, Dr. Deepak Bhatt, Dr. Hugh Calkins, and Dr. Biykem Bozkurt. They are responsible for overseeing and advising our clinical content team and distilling what’s most important for cardiologists to know throughout the year.
Purchase today to get 40% off and early access to these major updates before anyone else.

Doctor sitting at a table studying on her computer

Practice with Confidence

“It’s very different from [board review] in that the lectures are geared towards a topic and more practice-oriented.”

— Dr. Ramprasad G., PMA Medical Specialists

Stay Current With the Latest in Cardiology
  • Content from 75+ leading cardiologists.
  • 1,000+ journal articles distilled down to actionable insights + new topics added regularly.
  • 100+ AMA PRA Category 1 Credits™ + ABIM MOC points.
$549 /year
Billed Annually

Knowledge to Practice is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Successful completion of each CME activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to the ACCME for the purpose of granting ABIM MOC credit.

CurrentMD Cardiology is designed to be easy to use. As a result, getting your CME credits is quite straightforward. Simply complete the CME activities, and a transcript of your credits will be available in the “My Credits” section located at the top right of the page on your desktop.